FDA ordered three manufacturers of duodenoscopes, a device that was linked to outbreaks of antibiotic-resistant infections at a Washington hospital and in other health care facilities around the country, to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings. This comes after Senate health committee ranking Democrat Patty Murray (WA) pushed for a full review in March of FDA practices surrounding duodenoscopes, questioning why the agency waited so long to issue final guidance tightening...